News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR celebrates Royal Society of Chemistry blue plaques for cancer drug discovery
The ICR has been recognised for its many successes in drug discovery through the award of blue plaques in Sutton and Chelsea under the Royal Society of Chemistry’s Chemical Landmark scheme.
Giving birth increases women’s breast cancer risk in the short term
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children.
Immunotherapy appeal raises over £80,000 for our research
Thanks to the generosity of our donors, we have raised over £80,000 to help fund our cutting-edge work in immunotherapy through a fundraising appeal.
Targeted drug – palbociclib – stops tumour growth in patients with early breast cancer
Adding a new targeted therapy to hormone therapy halts the growth of tumour cells in women with early-stage breast cancer, new research shows.
Carols from Chelsea 2018: Christmas season starts in style with carol service for cancer research
Some famous faces from stage and screen came together to mark the start of the festive season and support the ICR at our exclusive carol service.
Making it count – the real life stories of people benefiting from innovative new cancer treatments
We are in an exciting time in cancer research, with many researchers believing we are at the tipping point in cancer treatment, and moving towards truly personalised treatment plans for patients.
New cancer drugs taking longer to reach NHS patients
NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals.
Scientific achievements of 2018
We've selected a range of discoveries from 2017/18 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
Immunotherapy keeps some patients with advanced head and neck cancer alive for more than three years
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.
Gene test predicts likelihood of stomach or oesophageal cancer relapse
A new test could improve care for patients with stomach or oesophageal cancer by predicting their likelihood of relapse after chemotherapy and surgery.
Weight loss drug could help treat advanced ovarian cancer
A weight loss drug available over the counter in the UK could help women with treatment-resistant ovarian cancer respond to chemotherapy again, a new study suggests.
Scientists uncover why testicular cancer runs in families
Testicular cancer in families is usually caused by the accumulation of minor genetic changes that have only a small effect on their own, but together can add up to a significant risk.
